The safety of stem cell therapy depends on the product being used and the clinic providing it. FDA-approved treatments for blood and immune conditions are well studied and considered safe when administered properly. But the unapproved joint, cosmetic, and anti-aging injections offered by most clinics are another matter. They come with documented serious harms and no required safety standard.
This guide explains those risks, reviews the FDA’s safety warnings and recorded adverse events, and outlines the questions to ask before agreeing to treatment. It doesn’t claim stem cell therapy works or is risk-free. Instead, it lays out what can go wrong so you can weigh the trade-offs for yourself.
Approved versus unapproved: the key split
Stem cell safety splits sharply between approved and unapproved uses. That split matters more than any single side effect.
- Approved uses (cord blood and bone marrow transplants for blood cancers, Ryoncil for a childhood condition) go through strict testing. Risks are known and managed.
- Unapproved uses (knee, hip, back, hair loss, anti-aging injections) skip that testing. Safety varies clinic to clinic, and problems are underreported.
So “is it safe” has no single answer. A cord blood transplant in a hospital and a cash-only knee injection at a strip-mall clinic are not the same risk.
Common side effects
Most side effects are mild and short-lived, but they are real. The FDA notes that even minimally processed products carry risk.
- Pain, swelling, or bruising at the injection site.
- Temporary stiffness or a short flare of joint pain.
- Mild fever or fatigue after an infusion.
These usually fade within days. They are the price of entry, not the main concern.
The serious risks
The serious risks are rarer but can be permanent, and they are why regulators act. The pattern is consistent across the documented cases.
Infection. Poorly processed cells can carry bacteria. The CDC has documented bloodstream infections, joint infections, and epidural abscesses after unapproved injections.
Blindness and organ damage. Three women lost vision after a fat-derived stem cell injection for macular degeneration at a Florida clinic. The FDA’s consumer alert followed that and similar cases.
Tumors, including cancer. Cells injected in the body can, rarely, grow into tumors, including cancerous growths, in places they should not. Reviews have recorded these growths, along with lesions, among adverse events.
Clots and reactions. Infusions have been linked to pulmonary embolism, cardiac events, and immune reactions to donor cells. A few reported cases ended in death.
Adverse events at a glance
| Harm | Where reported | Typical setting |
|---|---|---|
| Site infection / abscess | CDC, FDA reports | Unapproved injections |
| Bloodstream infection | CDC report | Contaminated products |
| Vision loss / blindness | FDA alert, Florida cases | Eye injections |
| Tumors or abnormal growths | Adverse-event reviews | Unapproved products |
| Blood clots, cardiac events | Adverse-event reviews | IV infusions |
This table lists harms that have been documented, not their frequency. Good frequency data barely exists, because unapproved clinics are not required to report outcomes. That reporting gap is itself a safety problem.
Why unapproved products are riskier
Unapproved products are riskier because no one checks them before they reach you. Approved drugs pass through manufacturing controls, sterility testing, and dose standards. A cash-pay injection may skip all three.
There is no required proof the product is sterile, no standard dose, and often no plan for handling a complication. Clinics that hide their sterility and screening details are often the same ones making the boldest claims. The two problems tend to travel together, so treat missing safety information as a warning sign.
Donor products add another layer. Umbilical and amniotic products can carry donor-borne infection if screening is weak, and some, as the FDA warns, contain no live cells at all.
Your own cells vs donor cells
Cells from your own body usually carry less risk, but they are not risk-free. Autologous cells rarely trigger rejection because your immune system recognizes them. That removes one category of harm.
Donor (allogeneic) cells add contamination and immune-reaction risk. They are marketed as “younger and more potent,” but potency claims do not cancel safety questions. Either way, the injection itself can introduce infection if handling is poor.
The cell source changes the risk picture too: see what is specific to adipose-derived stem cells (harvested from your own fat) and to mesenchymal stem cells (the cell type behind most clinic products).
The overseas safety gap
Safety risk often rises when you travel abroad for a cheaper injection. Clinics in some countries operate under lighter oversight than the FDA requires, and that changes the math.
Three specific gaps show up. First, cell screening and sterility standards may be weaker or unverifiable. Second, if a complication happens, you are far from the clinic and your regular doctors. Third, follow-up care falls on your home providers, who did not perform the procedure and may lack records.
A lower sticker price abroad can hide a higher total risk. Our guides on Mexico and where to go cover this trade-off. Cheaper is not the same as safer.
Aftercare and warning signs
Knowing the warning signs after treatment helps you catch a problem early. Most serious harms show up in the first days to weeks.
Call a doctor promptly if you notice spreading redness, worsening swelling, fever, severe or growing pain, or, after an eye procedure, any change in vision. These can signal infection or a serious reaction. Do not wait for a scheduled follow-up if something feels wrong. Ask the clinic, before you pay, exactly who handles an emergency and where you should go.
Questions to ask before you agree
The best way to lower your risk is to screen the clinic hard before paying. A safe clinic welcomes these questions.
- Is this product FDA approved for my condition? (For joints, the answer is no.)
- What exactly is in the product, and are the cells alive?
- How are the cells screened for infection and contamination?
- Who treats a complication, and where do I go at 2 a.m.?
- What does published, peer-reviewed research show for this exact use?
Vague or offended answers are the warning sign. Our how to vet a clinic guide turns these into a full checklist, and our FDA status page explains what “approved” really means.
The bottom line
Is stem cell therapy safe? Approved blood and immune treatments are, when done properly in a hospital. The unapproved joint, cosmetic, and anti-aging injections most clinics sell carry real, documented risks, from infection to blindness, without the safety testing that approved drugs require. Screen the clinic, ask the five questions above, and weigh these risks against a better-studied option like PRP or, for a structural problem, surgery. Our success rate guide shows how uncertain the benefit side of that trade-off really is. If the risk and the price both give you pause, our worth-it breakdown walks through the full decision.
Frequently asked questions
Is stem cell therapy safe?
It depends heavily on the product and the clinic. FDA-approved blood and immune treatments are well studied and safe when done properly. Unapproved joint, cosmetic, and anti-aging injections carry documented risks, including infection, blindness, and tumors, and are not held to the same safety standards.
What are the most common side effects?
The most common side effects are temporary pain, swelling, and bruising at the injection site. More serious but rarer harms include infection, immune reactions to donor cells, blood clots, and cells growing where they should not. Overseas or unregulated clinics raise these risks.
Has anyone been seriously harmed by stem cell treatment?
Yes. The FDA and CDC have documented serious harms from unapproved products, including three women blinded after an eye injection, bloodstream and joint infections, tumors, and deaths. These cases involved clinics operating outside FDA approval.
Are your own cells safer than donor cells?
Often, yes, but not automatically. Cells from your own body carry little rejection risk, but any injection can introduce infection if processing is poor. Donor umbilical or amniotic products add contamination and immune risks, and some contain no live cells.
What questions should I ask before a stem cell injection?
Ask whether the product is FDA approved for your condition, what cells it contains, how they are screened for infection, and who handles complications. A safe clinic answers plainly and in writing. Evasive answers are a red flag. See our vetting guide.
Can stem cell therapy make my condition worse?
Yes, in rare cases. Regulators have documented patients whose pain, swelling, or neurological symptoms got worse after an unapproved injection, most often from infection or an immune reaction to the injected cells. The FDA has warned that these unapproved products can cause serious harm.
Who should not get stem cell therapy?
Clinics commonly screen out a few groups before offering an injection: people with an active infection or fever, anyone with an active cancer diagnosis, and people who are pregnant. A bleeding disorder or blood-thinning medication can also rule out a joint injection until a doctor clears you. A careful clinic asks about your full medical history and current medications before treatment, not just your painful joint. A clinic that skips that screening is itself a warning sign.
Do I need to stay in the hospital for a stem cell injection?
Most joint, back, and cosmetic stem cell injections are outpatient procedures, so you go home the same day. That differs from a bone marrow or cord blood transplant for a blood cancer, which does require a hospital stay. That stay often runs for weeks, because the transplant rebuilds the entire blood and immune system. If a clinic proposes an inpatient stay for a routine joint injection, ask why, since that is not the norm for this kind of unapproved product.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.